PUBPOL 5113

Last Updated

  • Schedule of Classes - June 16, 2025 11:41AM EDT
  • Course Catalog - September 10, 2024 9:48AM EDT
Global toggle of class tabs

Links for textbooks and Cornell Store open in new tab.

PUBPOL 5113
Key Management Issues in the Biotech and Pharmaceutical Industries

Course information provided by the 2024-2025 Catalog. Courses of Study 2024-2025 is scheduled to publish mid-June.

This course provides an overview of the key management issues facing the pharmaceutical and biotechnology industries. The emphasis is on the United States because it is the largest and most profitable market, but we will briefly cover issues affecting global markets.


Permission Note Enrollment limited to: Sloan Executive Master of Health Administration (EMHA) students.

Last 4 Terms Offered (None)

Outcomes

  • Through this course, students will learn to analyze how decisions made throughout drug testing and development impact a drug's performance over its lifecycle.
  • Describe how firms set prices and negotiate with health insurers.
  • Anticipate the pros and cons of a merger, acquisition, or alliance opportunity.
  • Deconstruct and critique drug marketing strategies.

When Offered Fall.

View Enrollment Information

Syllabi: none

  •   Seven Week - First. 

  • 1 Credit Graded

  • 12990 PUBPOL 5113   LEC 001

  •  
    • TR Online Meeting
    • Aug 26 - Sep 28, 2024

    • Nicholson, S

  • Instruction Mode: Distance Learning-Synchronous